Interview: Dr. Amr Morsy – CEO, Rameda, Egypt
Five days before the January 25th revolution of 2011, Rameda changed ownership and CEO Amr Morsy set out to turn-around the mismanaged business. Five years later, revenues are up 4.5…
Rameda aims to become the most valuable emerging pharmaceutical company in Egypt. The company’s mission is to provide customers with quality health care solutions in a cost effective manner by developing products and services that satisfy their health requirements.
Rameda began operations in 1994 and was established by a group of Gulf investors with the intention of creating one of the largest pharmaceutical operations in the region.
Owners hired V-Konsult of Germany to create a state-of-the art design, and British Carter Construction company was contracted to build the Rameda’s facilities.
In 1999, Rameda entered into an agreement with Alcon to manufacture – under license – their ophthalmology products. In order to guarantee the quality of their products, Alcon built one of the highest quality eye production facilities in the region at Rameda.
In 2011, Compass Capital led a consortium of private equity investors for the acquisition of 100% of Rameda. Compass Capital plans to establish Rameda as a regional leader in the industry.
To execute this strategy Rameda hired a new management team with a proven track record to complement the existing team.
Contact
Cairo Scientific Office
8 Geziret El Arab Street (23rd Floor), Mohandessin, Giza, Egypt
+(202) 376 130 46 / 58 / 74
+(202) 376 130 18
Factory
Second Industrial Zone, plot number 5
Sixth of October, Egypt
+( 202) 383 31887 – 383 31848
+(202) 383 31849
Five days before the January 25th revolution of 2011, Rameda changed ownership and CEO Amr Morsy set out to turn-around the mismanaged business. Five years later, revenues are up 4.5…
Dr Sherif Rashed, managing partner and chairman of Magicpharma, explains how the company’s unique business model has allowed it to become one of the Top 50 pharmaceutical companies in Egypt…
Dr Wafik Bardissi, chairman and CEO of Minapharm, the only company to offer biosimilars in Egypt, highlights how the company has successfully developed biotech know-how by partnering with and acquiring…
Dr Mohamed Mabrouk, CEO of Pharmed Healthcare, highlights how the company has evolved from only offering Hepatitis C treatment to having 112 products in the pipeline today. He also emphasises…
Ashraf Elkhouly, executive director of the Egyptian Society for Pharmaceutical Research, discusses how recent healthcare reforms will help to attract more investment to Egypt and the importance of public-private partnerships…
Ahmed Elfangary, country manager of DHL Express Egypt, highlights the company’s leadership position in the Egyptian logistics field, while aiming to be a strong partner of the government. He also…
The 100 Million Seha (100 Million healthy lives) campaign, which kicked off on a national scale in October 2018 under the auspices of President Abdel Fattah El-Sisi, aims to detect…
Amro Kandil, managing director of Northeast Africa at GE Healthcare, emphasizes the company’s crucial role in improving healthcare in Egypt as part of a long-standing partnership with the Ministry of…
Ramez Mohsen, managing director at Janssen for Egypt, Jordan, Libya & Sudan, highlights how the company is driving real access to treatments in Egypt through collaboration with various stakeholders. He…
Ashraf Osman, president and CEO of AUG Pharma, explains how his company has become one of Egypt’s Top 30 pharmaceutical companies in less than four years of manufacturing, gives an…
Basyouni Abuseif, country president and CPO Head at Novartis Egypt, explains how the Swiss company has taken over the leadership position in the Egyptian pharmaceutical market despite economic and political…
Dr Maged George, chairman of the Egyptian Export Council of Medical Industries, highlights the obstacles that the Egyptian pharmaceutical industry is facing in the wake of the currency devaluation both…
Christelle Saghbini, the newly appointed chairman & managing director of Sanofi for Egypt & Sudan, highlights her strategic roadmap for bringing access to innovative medicines to Egypt. She also explains…
See our Cookie Privacy Policy Here
